U.S. Markets open in 8 hrs, 49 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,344.84 | 34.92 | 0.34% |
| NASDAQ | 2,144.60 | 6.16 | 0.29% |
| S&P 500 | 1,095.63 | 4.14 | 0.38% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.76 | Current P/E Ratio: | -9.53947 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.21 | Current Quarter Estimate: | -0.199 |
| Last Fiscal Year Earnings: | -0.69 | Next Fiscal Year Estimate: | -0.416 |
| Analyst Consensus: | Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 03/01/2010 * | 18:00 | Q4 2009 Allos Therapeutics, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/17/2009 | Allos Therapeutics, Inc. at Lazard Capital Healthcare Conference |  |
— |
| 11/03/2009 | Q3 2009 Allos Therapeutics, Inc. Earnings Conference Call | |
Download($) |
| 11/03/2009 | Q3 2009 Allos Therapeutics, Inc. Earnings Release | — | — |
| 09/25/2009 | Allos Therapeutics, Inc. Conference Call to Discuss FOLOTYN: First and Only FDA-Approved Therapy for Relapsed or Refractory PTCL | |
Download($) |
| 09/03/2009 | Allos Therapeutics, Inc. to Hold Post Advisory Committee Conference Call | |
Download($) |
| 08/04/2009 | Q2 2009 Allos Therapeutics, Inc. Earnings Conference Call | |
Download($) |
| 08/04/2009 | Q2 2009 Allos Therapeutics, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts